Form 10-Q TENAX THERAPEUTICS, INC. For: Jan 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Tenax Therapeutics (TENX) Tops Q3 EPS by 6c
March 18, 2015 6:10 AM EDTTenax Therapeutics (NASDAQ: TENX) reported Q3 EPS of ($0.10), $0.06 better than the analyst estimate of ($0.16).
For earnings history and earnings-related data on Tenax Therapeutics (TENX) click here.
... More